|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Effect of C-Peptide on Diabetic Peripheral Neuropathy, a 6 Months Randomized Double-Blind, Placebo Controlled, Dose-Finding, Multicenter Study, With Parallel Groups
The aim of the study is to investigate the effect of C-peptide administration on nerve function in patients with type 1 diabetes and peripheral sensory neuropathy.
100 Clinical Results associated with Creative Peptides Sweden AB
0 Patents (Medical) associated with Creative Peptides Sweden AB
100 Deals associated with Creative Peptides Sweden AB
100 Translational Medicine associated with Creative Peptides Sweden AB